Accessibility Skip to:
  • Accessibility Policy
  • Main Content
  • Main Menu
  • Contact

  • -A: Font Smaller
  • +A: Font Larger
  • Reset Font
  • High Contrast
  • Low Contrast
  • Reset Contrast
History:
You are here:
  • Grand Challenges Canada
  • >
  • Innovations
  • >
  • 1905-25094
  • Français
  • About Us
    • Who We Are
    • Annual Letter
    • Annual Report
    • Evaluations
    • Innovations & Results
    • Governance
    • Partnerships
    • Employment Opportunities
  • Programs
    • Global Mental Health
    • Humanitarian Grand Challenge
    • Indigenous Innovation Initiative
    • OPTions Initiative
    • Saving Brains
    • Saving Lives at Birth
    • Stars in Global Health
    • Transition To Scale
  • Funding & Resources
    • Funding Opportunities
    • Service Opportunities
    • Integrated Innovation
    • Gender Equality Portal
    • Policies & Other Resources
  • News & Media
    • News
    • Blog
    • Photos
    • Videos
    • Contact Us
Grand Challenges Canada

Bold Ideas with Big Impact®

Browse our Innovations and Results
  • Get to Know Us
    • Who We Are
    • Co-CEOs
    • Governance
    • Accountability
    • The Team
    • Partnerships
    • Career Opportunities
    • Service Opportunities
    • Contact Us
  • Learn What We Do
    • What We Do
    • Global Health
    • Humanitarian
    • Indigenous
    • Transition To Scale
    • Innovation Marketplace
    • Innovations & Results
    • Annual Report
  • See Our Impact
  • Apply for Funding
    • Funding Opportunities
    • Innovator Resources
    • Gender Equality Portal
  • Get Informed
    • News and Media
    • Blog
    • Publications
    • Subscribe
    • Photos and Videos
  • Accessibility
  • Contact
  • Français

Home » Innovations » 1905-25094

MAMaZ Against Malaria: An evidence-based intervention to treat severe malaria

FacebookTwitterLinked In

Start Date: 01/12/2018- End Date: 30/11/2020


Project Lead(s): Tendayi Kureya

Despite the progress having been made in malaria control, more than 16 million people remain at risk of malaria in Zambia. In an effort to reduce preventable mortality and morbidity from severe malaria among children aged six months to six years, MAMaZ Against Malaria will introduce pre-referral rectal artesunate suppositories, a life-saving drug for the treatment of severe malaria, in hard-to-reach communities in Zambia.

  • Innovation Overview
    Program

    Transition to Scale

    Institution

    Development Data

    Institution Country

    Zambia

    Implementation Country

    Zambia

    Implementation Region

    Sub-Saharan Africa

    Priority

    Infectious Diseases

    Platform

    Behaviour Change Communication, Community Health Worker Training, Drug, Health Provider training, Non-health provider training, Peer education, Public-private partnership, Service Delivery, Supply chain management, Task-shifting

Grand Challenges Canada’s programs are primarily undertaken with the financial support of the Government of Canada provided through Global Affairs Canada.

Government of Canada
  • Fluxx Technical Support
  • Privacy Policy
  • Website Legal Terms and Disclaimer